From Wikipedia, the free encyclopedia
Jump to: navigation, search
6-MAPB structure.png
Systematic (IUPAC) name
Clinical data
Legal status
  • AU: Analogue of MDMA
  • CA: Analogue of amphetamine
  • UK: Temporary class drug
  • US: Analogue of MDMA
CAS Number 1354631-79-0
ChemSpider 32078890
Chemical data
Formula C12H15NO
Molecular mass 189.25

6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives.[citation needed] 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.[1]

See also[edit]


  1. ^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-10.